GMR Solutions (GMRS) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- -$1.56
- Estimate
- $0.32
- Surprise
- -582.9%
- Revenue (period 2026-06-30)
- $1.49B
- Score today
- 5.9/10
Revenue source: xbrl.
How the report landed
GMR Solutions (GMRS) reported a wider loss than forecast — adjusted EPS of -$1.56 against the $0.32 estimate (a 582.9% shortfall).
Coverage in the report window
- GMR Solutions Affirms FY2026 Sales Guidance of $5.890B-$6.180B vs $6.018B Est — benzinga, 2026-08-12
- GMR Solutions Q2 EPS $(1.84) Misses $(0.16) Estimate, Sales $1.490B Beat $1.469B Estimate — benzinga, 2026-08-12
Where TrendMatrix's rating stands now
TrendMatrix currently rates GMRS Sell at 5.9/10; no pre/post engine snapshot brackets this report.
What argues against it
- Risk below floor (2.3 < 2.5)
- Insider activity: 5.01%=extreme
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $10.62
- Price target
- $16.20
- Stop
- $9.88
- Upside to target
- +52.5%
- Reward-to-risk
- 3.5:1
Model outputs from TrendMatrix’s engine as of 2026-10-13 — shown for context, not personalized investment advice.
GMRS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Care Facilities
- Market cap
- $572.6M
- P/E (fwd)
- 5.9
- 52-week range
- $9.00–$15.98
- Off 52-week high
- 33.5%
- RSI (14)
- 45
- Volume vs avg
- 0.51×
- Score today
- 5.9/10